Morfine Sulphate Aurobindo (Morphine Sulfate)

Morphine sulfate, the active ingredient in Morfine Sulphate Aurobindo, is an opioid analgesic presented as an oral formulation for oral use. It treats severe acute pain, post‑operative pain, cancer pain and chronic pain requiring opioid therapy.

GNH USA supplies Morfine Sulphate Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Morphine sulfate is used to manage pain conditions that involve the opioid pathway.

- Severe acute pain: provides rapid analgesia to reduce intense pain episodes. - Post‑operative pain: helps control pain after surgical procedures to facilitate recovery. - Cancer pain: offers strong relief for malignant disease‑related discomfort. - Chronic pain requiring opioid therapy: maintains long‑term pain control when other treatments are insufficient.

Morphine sulfate may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea - Constipation - Drowsiness - Dizziness - Vomiting - Sweating

Serious or Rare Side Effects: - Respiratory depression - Severe hypotension - Anaphylactic reaction - Adrenal insufficiency - Dependence or addiction - Respiratory arrest

When prescribing morphine sulfate, clinicians should consider several safety measures. - Assess pain severity: ensure opioid therapy is appropriate for the level of pain. - Monitor respiratory function: watch for signs of respiratory depression, especially after dose initiation. - Evaluate substance‑use history: screen for prior opioid misuse or dependence. - Use caution in renal or hepatic impairment: dose adjustments may be required. - Avoid concurrent CNS depressants: limit use with benzodiazepines or alcohol. - Store at ambient temperature: keep in the original container, protect from moisture.

Morphine sulfate can interact with other medications, influencing its safety and efficacy.

Major Interactions (Avoid): - Other opioids: increased risk of respiratory depression. - Central nervous system depressants (e.g., benzodiazepines): additive sedation. - Monoamine oxidase inhibitors: heightened serotonergic effects. - Alcohol: potentiates CNS depression. - Respiratory depressants: may cause severe breathing suppression.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors or inducers: may alter morphine plasma levels. - Antihistamines: can increase sedation. - Diuretics: may affect electrolyte balance. - Antidepressants (SSRIs/SNRIs): risk of serotonin syndrome. - Anticholinergics: may exacerbate constipation.